Immunotherapy & Targeted Therapy

Personalised, biomarker-driven treatments — including checkpoint inhibitors and targeted oral therapies for eligible patients.

Where appropriate, consultants assess biomarkers, tumour type, previous treatment, and patient fitness to determine whether immunotherapy or targeted therapy may be suitable.